Algorae Pharmaceuticals Limited (ASX:1AI)
0.0080
-0.0010 (-11.11%)
At close: Aug 29, 2025
Algorae Pharmaceuticals Revenue
In the fiscal year ending June 30, 2025, Algorae Pharmaceuticals had annual revenue of 141.05K AUD with 12.66% growth.
Revenue
141.05K
Revenue Growth
+12.66%
P/S Ratio
95.70
Revenue / Employee
2.94K
Employees
48
Market Cap
13.50M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 141.05K | 15.85K | 12.66% |
Jun 30, 2024 | 125.20K | 83.18K | 197.98% |
Jun 30, 2023 | 42.02K | 38.61K | 1,133.95% |
Jun 30, 2022 | 3.41K | -264.78K | -98.73% |
Jun 30, 2021 | 268.18K | -285.51K | -51.56% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.12B |
Ansell | 3.06B |
Telix Pharmaceuticals | 1.01B |
Mesoblast | 26.23M |